GW&K Investment Management LLC lowered its holdings in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 0.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 343,932 shares of the medical instruments supplier’s stock after selling 252 shares during the quarter. GW&K Investment Management LLC owned about 0.46% of West Pharmaceutical Services worth $48,777,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in WST. FMR LLC raised its holdings in shares of West Pharmaceutical Services by 41.3% during the 1st quarter. FMR LLC now owns 794 shares of the medical instruments supplier’s stock valued at $88,000 after purchasing an additional 232 shares in the last quarter. Zions Bancorporation N.A. raised its holdings in West Pharmaceutical Services by 3.0% in the 2nd quarter. Zions Bancorporation N.A. now owns 5,242 shares of the medical instruments supplier’s stock worth $656,000 after acquiring an additional 155 shares during the period. First Citizens Bank & Trust Co. bought a new position in West Pharmaceutical Services in the 2nd quarter worth $627,000. First Hawaiian Bank raised its holdings in West Pharmaceutical Services by 29.2% in the 2nd quarter. First Hawaiian Bank now owns 2,239 shares of the medical instruments supplier’s stock worth $280,000 after acquiring an additional 506 shares during the period. Finally, Oregon Public Employees Retirement Fund raised its holdings in West Pharmaceutical Services by 1.4% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 29,970 shares of the medical instruments supplier’s stock worth $3,751,000 after acquiring an additional 424 shares during the period. Institutional investors and hedge funds own 91.07% of the company’s stock.
WST traded down $0.06 during trading on Friday, hitting $147.73. The stock had a trading volume of 520,762 shares, compared to its average volume of 368,027. The firm has a market cap of $10.87 billion, a PE ratio of 52.57, a P/E/G ratio of 3.34 and a beta of 1.25. West Pharmaceutical Services Inc. has a 12 month low of $91.75 and a 12 month high of $152.10. The company has a current ratio of 3.00, a quick ratio of 2.31 and a debt-to-equity ratio of 0.17. The company has a 50 day simple moving average of $142.41 and a 200-day simple moving average of $132.19.
West Pharmaceutical Services (NYSE:WST) last announced its earnings results on Thursday, October 24th. The medical instruments supplier reported $0.79 EPS for the quarter, topping the consensus estimate of $0.71 by $0.08. West Pharmaceutical Services had a net margin of 12.82% and a return on equity of 16.66%. The firm had revenue of $456.10 million for the quarter, compared to the consensus estimate of $450.03 million. During the same quarter last year, the firm posted $0.76 EPS. The business’s quarterly revenue was up 5.6% on a year-over-year basis. As a group, sell-side analysts anticipate that West Pharmaceutical Services Inc. will post 3.14 earnings per share for the current fiscal year.
Several research analysts recently commented on the stock. ValuEngine downgraded shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Zacks Investment Research upgraded shares of West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $160.00 target price on the stock in a report on Sunday, November 3rd. Finally, Bank of America upgraded shares of West Pharmaceutical Services from an “underperform” rating to a “neutral” rating in a report on Friday, July 26th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. West Pharmaceutical Services has an average rating of “Hold” and a consensus target price of $131.39.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.
Further Reading: Dividend Yield
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.